Cheapest GLP-1 in 2026: The Lowest-Cost Way to Get Each Drug

"Cheapest" depends entirely on whether your insurance covers the drug. If it does, no cash program comes close. If it does not, the order flips and a handful of self-pay routes become the floor. This page ranks every legitimate access path from cheapest to most expensive, then tells you the single cheapest option for each individual drug — so you can stop comparing apples to oranges.

For the full grid of drugs against every payment method, see the GLP-1 price comparison. For coverage mechanics, the insurance guide and coupons and savings programs go deeper.

Direct answer: The cheapest GLP-1 in 2026 is any branded drug with commercial insurance plus a manufacturer savings card — $0–$25/month. If you have no coverage, the cheapest legitimate options are the oral drugs (Wegovy pill, Foundayo) from $149/month, then Zepbound vials from $299/month via LillyDirect, then GoodRx or NovoCare self-pay at $199 intro/$349 for injectable Ozempic and Wegovy. Compounded semaglutide ($141–$199) is cheaper still but was restricted by the FDA in April 2026 — patient-specific telehealth routes like Yücca still prescribe it from $125/month on a six-month plan — and grey-market retatrutide ($150+) is the lowest number of all and the least regulated.

Access paths, ranked cheapest to most expensive

1. The cheapest legitimate path: insurance + a savings card

If your commercial plan covers obesity or diabetes drugs, the manufacturer copay card is unbeatable: $0–$25/month for 12–24 months. The Wegovy and Ozempic Savings Cards and the Lilly Zepbound and Mounjaro cards all work this way. Nothing in the cash market gets close. The only reason people skip it is that their plan excludes the drug — common with employer plans that carve out weight-loss medications. If you are not sure, the insurance coverage guide walks through checking your formulary and appealing a denial. Card terms differ by drug — we break down each one in the Zepbound, Wegovy, Mounjaro, and Ozempic savings-card guides.

2. Free drug: patient assistance programs

Both manufacturers run patient assistance programs that provide the drug at no cost to people who are uninsured and below an income threshold (typically around 400% of the federal poverty level). These are not advertised heavily and require documentation, but for qualifying patients they are the literal cheapest option — $0. Details and links are in the savings programs guide.

3–4. Cheapest cash routes: oral drugs and Zepbound vials

For the uninsured, the cash floor in 2026 is:

• Oral semaglutide (Wegovy pill) and Foundayo (orforglipron): from $149/month. The lowest entry point for a branded, FDA-cleared GLP-1. Doses are lower than the maximum injectables, but for many people they are enough to start. See the pill comparison and oral vs injectable Wegovy.
• Zepbound single-dose vials via LillyDirect: $299 (2.5 mg), $399 (5 mg), $449 (higher doses). The cheapest branded tirzepatide, and tirzepatide is the strongest approved molecule for weight loss. The catch is the Self Pay Journey Program requires refilling within 45 days to hold the discount. For every route to a lower price on each drug — cards, self-pay, and discount cards side by side — see the Zepbound, Wegovy, Mounjaro, and Ozempic coupon guides.

5–7. The middle: Medicare, Costco, and self-pay injections

• Medicare GLP-1 Bridge (July 2026): eligible Part D beneficiaries get Wegovy, Zepbound, and Foundayo at roughly $50/month — a major change from prior exclusion of obesity drugs.
• Costco + Sesame: Costco members buy Wegovy or Ozempic at $349/month ($199 for the first two months). Covered in the pharmacy pricing map.
• NovoCare or GoodRx self-pay: injectable Ozempic and Wegovy at $199/month introductory for the first two fills, then $349/month at standard doses — $399 for Wegovy HD 7.2 mg and $499 for Ozempic 2 mg (NovoCare Pharmacy, checked August 2026). The standard cash route when you want a name-brand injectable without insurance.

For the full menu of telehealth services that bundle the visit with the prescription, see GLP-1 online.

8–9. Cheaper but riskier: compounded and research peptides

Compounded semaglutide and tirzepatide were the budget favorite at $141–$500/month, but the FDA removed semaglutide, tirzepatide, and liraglutide from the bulk-compounding list in April 2026, so large-scale compounding is no longer permitted. What is left is narrower 503A patient-specific compounding. These products are not FDA-approved. See compounded tirzepatide.

The route we point people to: Yücca telehealth — an online evaluation with a licensed clinician who, if you qualify, prescribes compounded Semaglutide+ or Tirzepatide+ filled by a licensed US pharmacy, from $146/month for Semaglutide+ or $258/month for Tirzepatide+. That is the lowest doctor-prescribed price we track without insurance — just under the $149 oral floor, with an actual prescription and pharmacy behind it. (Partner link: we may earn a commission, at no extra cost to you.)

Retatrutide is the cheapest number anyone will quote you — research peptide vendors sell it from $150/month — but it is investigational, sold without a prescription or pharmacy, and carries no guarantee of identity, purity, or dose. We cover where it is sold and the no-prescription reality honestly rather than pretending the price comes free of risk.

Cheapest GLP-1 without insurance: the lowest price for each drug

The ranking above compares paths. This is the same question asked drug by drug — if you are paying cash, what is the floor for the specific medication you want?

Novo Nordisk figures are the self-pay prices published by NovoCare Pharmacy and were re-checked in August 2026; the Lilly figures carry this page's 4 August 2026 price check.

Three things that table makes obvious and a headline number never does:

• The tablets price by dose; the pens mostly do not. $149/month buys the 1.5 mg starting dose of oral semaglutide. Step up to 9 mg or 25 mg and you are paying $299 — the same as an entry-dose Zepbound vial, for a tablet whose ceiling still sits below the maximum injectable doses.
• The $199 injectable price is an introduction, not a price. It covers two monthly fills and the offer runs through 31 December 2026, after which the standard doses sit at $349.
• Cheapest to start and cheapest to stay on are different questions. Work out the cost at the dose you expect to maintain, not the dose you begin at, then compare.

When "cheap" is a red flag

Some prices are low because something is wrong. Walk away if you see: Prices move every quarter, so a second cheapest GLP-1 ranking is a quick way to confirm nothing has shifted since this was updated.

• No prescription and no medical evaluation. Any legitimate GLP-1 — branded or compounded — requires a clinician. A site that skips this is not a pharmacy.
• "FDA-approved" claims on compounded or peptide products. Compounded and research products are by definition not FDA-approved. The claim itself is the red flag.
• Prices far below the floor. Branded injectable semaglutide under ~$149 from a non-manufacturer source, or "Ozempic" for $40, is almost certainly counterfeit.
• No pharmacy licensing, no pharmacist access, wire-transfer-only payment. Standard markers of an illegitimate seller.

What people get wrong

• "Compounded is automatically the cheapest." After April 2026, manufacturer self-pay ($149–$349) is competitive with — and safer than — what remains of compounding.
• "I make too much for assistance, so cash is my only option." Maybe not. A savings card with even partial insurance coverage beats every cash route.
• "Cheapest drug = cheapest path." The drug and the access path are separate decisions. The cheapest path (insurance + card) makes the choice of drug almost free either way.
• "The $149 oral works as well as the max injectable." Lower doses generally mean more modest results. Cheapest entry point is not the same as strongest outcome — see which GLP-1 is best for weight loss.

Frequently asked questions

What is the single cheapest GLP-1 right now? With commercial insurance plus a manufacturer savings card, $0–$25/month for any branded drug. Without insurance, the Wegovy pill or Foundayo from $149/month, or Zepbound vials from $299/month.

What is the cheapest GLP-1 without insurance? Oral options (Wegovy pill, Foundayo) at $149/month are the lowest branded entry point. For an injectable, Zepbound vials via LillyDirect start at $299/month. Doctor-prescribed compounded semaglutide through Yücca comes in slightly lower, from $125/month on a six-month plan.

Is it cheaper to buy GLP-1 online? Online telehealth self-pay roughly matches pharmacy self-pay ($199 intro, $349 ongoing) and saves you a separate visit fee. See GLP-1 online for the provider comparison.

Is compounded GLP-1 still cheaper in 2026? Sometimes, but the FDA restricted bulk compounding in April 2026, so availability shrank and the price advantage over manufacturer self-pay largely disappeared. Where patient-specific compounding survives — Yücca is the example we link above — it starts at $125/month on a six-month plan, still under every branded cash route.

Why is retatrutide so cheap? Because it is not a finished, approved, pharmacy-dispensed drug. It is an investigational molecule sold as a research peptide, which removes the regulatory and manufacturing costs — and the safety guarantees. See retatrutide cost.

What is the cheapest GLP-1 pill? Oral semaglutide is the cheapest tablet at $149/month for the 1.5 mg starting dose through NovoCare Pharmacy, dispensed as either the Wegovy pill or the Ozempic pill (checked August 2026). The price rises with dose: $199/month at 4 mg and $299/month at 9 mg and 25 mg. Foundayo (orforglipron), Lilly's oral tablet, also starts at $149/month.

Are GLP-1 tablets less expensive than injections? At the starting dose, yes — $149/month for a tablet against $199 introductory and $349 ongoing for a pen. At the top dose the gap closes: oral semaglutide at 9 mg or 25 mg is $299/month, the same as the entry-dose Zepbound vial and only $50 under the ongoing pen price. Tablets are the cheapest way to start, not automatically the cheapest way to stay on.

Which GLP-1 provider is the cheapest? It depends what you mean by provider. For the drug alone, the manufacturers' own pharmacies undercut retail: NovoCare Pharmacy for Wegovy and Ozempic, LillyDirect for Zepbound. For the prescription and the drug bundled together, Costco members buy through Sesame, and telehealth services price by plan length rather than by pharmacy — Yücca, for example, is $125/month on a six-month plan against $146 month-to-month for compounded Semaglutide+. No provider beats a commercial insurance plan that covers the drug plus a manufacturer savings card, which lands at $0–$25.

Last reviewed: August 20, 2026

Sources

• GLP-1 Drug Savings: How to Save on Ozempic, Wegovy, and More — GoodRx
• Discounts on GLP-1 Medications — GoodRx
• NovoCare Pharmacy — Novo Nordisk
• Authentic Zepbound Shipped to You — LillyDirect
• Lilly Lowers Price of Zepbound Single-Dose Vials — Eli Lilly
• A New Medicare Option for Weight-Loss Drugs Is Coming — NPR
• Costco Members Can Now Get Half-Priced Ozempic and Wegovy Through Sesame

References

• FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — U.S. FDA
• FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List — U.S. FDA
• Tirzepatide as Compared with Semaglutide for Obesity (SURMOUNT-5) — New England Journal of Medicine